Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.66% |
| 3 | Healthcare | 7.12% |
| 4 | Industrials | 5.11% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Incyte
INCY
$26.1B
| $18.1M | 0.01% |
238,798
-272,549
| -53% | -$20.7M |
|
1402
Reliance Steel & Aluminium
RS
$19.9B
| $18.1M | 0.01% |
106,647
+83,773
| +366% | +$15.6M |
|
1403
Fate Therapeutics
FATE
$302M
| $18.1M | 0.01% |
729,771
+419,627
| +135% | +$11.6M |
|
1404
CALL
Manulife Financial
MFC
$71.9B
| $18.1M | 0.01% |
810,000
| – | – |
|
|
ACQR
1405
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
| $18.1M | 0.01% |
1,844,755
+38,360
| +2% | +$376K |
|
1406
Allstate
ALL
$65.8B
| $18M | 0.01% |
142,107
-895,787
| -86% | -$117M |
|
1407
PUT
Prudential Financial
PRU
$41.5B
| $18M | 0.01% |
188,200
-86,100
| -31% | -$9.11M |
|
1408
MSC Industrial Direct
MSM
$6.8B
| $18M | 0.01% |
239,453
+156,483
| +189% | +$12.8M |
|
|
HCP
1409
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $18M | 0.01% |
610,737
+354,725
| +139% | +$14.3M |
|
1410
McGrath RentCorp
MGRC
$2.81B
| $17.9M | 0.01% |
235,825
+89,174
| +61% | +$7.27M |
|
1411
Eagle Materials
EXP
$6.16B
| $17.9M | 0.01% |
162,572
-135,437
| -45% | -$16.7M |
|
1412
PUT
PNC Financial Services
PNC
$98.1B
| $17.8M | 0.01% |
112,600
-77,600
| -41% | -$13M |
|
1413
Saic
SAIC
$5.33B
| $17.7M | 0.01% |
190,459
+86,348
| +83% | +$7.55M |
|
|
FTPA
1414
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
| $17.7M | 0.01% |
1,802,853
| – | – |
|
|
NSTD
1415
DELISTED
Northern Star Investment Corp. IV
NSTD
| $17.7M | 0.01% |
1,804,791
+302,435
| +20% | +$2.96M |
|
1416
Cirrus Logic
CRUS
$5.55B
| $17.7M | 0.01% |
243,564
-860,237
| -78% | -$66.7M |
|
1417
Cathay General Bancorp
CATY
$4.14B
| $17.6M | 0.01% |
450,623
+293,265
| +186% | +$12M |
|
1418
NeoGenomics
NEO
$2.17B
| $17.6M | 0.01% |
2,164,263
+1,626,337
| +302% | +$15.5M |
|
1419
Jack in the Box
JACK
$313M
| $17.6M | 0.01% |
313,963
+307,248
| +4,576% | +$23.3M |
|
|
SWAV
1420
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $17.6M | 0.01% |
91,981
-497,905
| -84% | -$87.9M |
|
1421
State Street SPDR S&P Biotech ETF
XBI
$11.7B
| $17.6M | 0.01% |
236,542
-606,972
| -72% | -$45.6M |
|
1422
AngloGold Ashanti
AU
$59.9B
| $17.6M | 0.01% |
1,187,190
+729,600
| +159% | +$13.8M |
|
1423
Danaos Corp
DAC
$2.69B
| $17.5M | 0.01% |
277,982
+265,413
| +2,112% | +$21.3M |
|
1424
Merit Medical Systems
MMSI
$5.32B
| $17.5M | 0.01% |
322,572
-29,816
| -8% | -$1.82M |
|
1425
Vir Biotechnology
VIR
$1.77B
| $17.5M | 0.01% |
687,199
-4,060,995
| -86% | -$94.8M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.